Multisystem inflammatory syndrome in children in the context of coronavirus disease 2019 pandemic

Multisystem inflammatory syndrome in children (MIS-C) is a complex syndrome characterized by multi-organ involvement that has emerged in the context of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreak. The clinical presentation of MIS-C is similar to Kawasaki disease but predominantly presents with fever and gastrointestinal symptoms, and severe cases can involve toxic shock and cardiac dysfunction. Epidemiological findings indicate that the majority of MIS-C patients test positive for SARS-CoV-2 antibodies. The pathogenesis and pathophysiology of MIS-C remain unclear, though immune dysregulation following SARS-CoV-2 infection is considered a major contributing factor. Current treatment approaches for MIS-C primarily involve intravenous immunoglobulin therapy and symptomatic supportive care. This review article provides a comprehensive overview of the definition, epidemiology, pathogenesis, clinical presentation, diagnosis, treatment, and prognosis of MIS-C.

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:26

Enthalten in:

Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics - 26(2024), 1 vom: 15. Jan., Seite 98-102

Sprache:

Chinesisch

Weiterer Titel:

新型冠状病毒感染流行背景下的儿童多系统炎症综合征

Beteiligte Personen:

Zhou, Bin [VerfasserIn]
Huang, Yu-Kun [VerfasserIn]
Hong, Shao-Xian [VerfasserIn]
Jiao, Fu-Yong [VerfasserIn]
Xie, Kai-Sheng [VerfasserIn]

Links:

Volltext

Themen:

Child
Coronavirus disease 2019
English Abstract
Journal Article
Multisystem inflammatory syndrome in children
Review
Severe acute respiratory syndrome coronavirus 2

Anmerkungen:

Date Completed 26.01.2024

Date Revised 28.01.2024

published: Print

Citation Status MEDLINE

doi:

10.7499/j.issn.1008-8830.2306093

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM367598930